- +1 (214) 929-7614
- info@goodnewsilluminer.com
There is also a similar class of medications called dual GLP-1/GIP receptor agonists. There is currently one of these medications on the market: tirzepatide (Mounjaro®).
GLP-1 agonists for obesity
The FDA currently approves the use of semaglutide and high-dose liraglutide for the treatment of obesity. This is because these GLP-1 agonists have weight loss effects.
How often do you take GLP-1 agonists?
Your healthcare provider will tell you when and how often to take your medi- cation (usually injections). Be sure to follow their instructions. However, in general, the frequencies of the injections are:
•Dulaglutide: once a week
•Exenatide: twice a day
•Exenatide extended release: once a week
•Liraglutide: once a day
•Lixisenatide: once a day
•Semaglutide: once a week
•Tirzepatide: once a week
•Semaglutide tablets: daily
What are the potential benefits of GLP-1 agonists?
•Lowering blood pressure
•Improving lipid disorders
•Improving fatty liver disease
•Reducing your risk of heart disease and kidney disease
•Delaying the progression of diabe- tes-related nephropathy
•Reduced symptoms of depression and anxiety
•Improved mood and cognitive function, which may help with alcohol and substance use disorders by targeting the brain’s dopamine reward system
•May lower the risk of specific cancers, like endometrial and ovarian cancers
Dr. Jasmine Jacob is a family nurse practitioner specializing in neurology/sleep medicine. She is currently working in a state county hospital in Dallas, Texas. Her expertise includes a variety of sleep disorders, insomnia, narcolepsy, and neuromuscular disorders.
Australia has just begun enforcing a new law that effectively locks children under 16 out...
GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels...
LIDDELL’S CHOICE TO GIVE UP HIS SPECIALTY EVENT AND PURSUE SOMETHING NEW SHOWED THE WORLD...